专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

CA283328A DEVICE FOR CHARGING FURNACES 未知
公开(公告)号：CA283328A
公开(公告)日：1928-09-18
申请号：CA283328D
申请人： SCOTT ANDREW , NEWCOMBE STEPHEN
发明人： NEWCOMBE STEPHEN , SCOTT ANDREW

2. 发明专利

CA172362A RACK 未知
公开(公告)号：CA172362A
公开(公告)日：1916-10-10
申请号：CA172362D
申请日：1914-12-14
申请人： SCOTT ANDREW
发明人： SCOTT ANDREW

3. 发明专利

CA283646A REFUSE FURNACE 未知
公开(公告)号：CA283646A
公开(公告)日：1928-10-02
申请号：CA283646D
申请人： REBER JAMES WILSON , SCOTT ANDREW
发明人： REBER JAMES WILSON , SCOTT ANDREW

4. 发明专利

GB191108837A Improvements in Boot and Shoe Fastenings. 未知
公开(公告)号：GB191108837A
公开(公告)日：1912-04-10
申请号：GB191108837D
申请日：1911-04-10
申请人： SCOTT ANDREW
发明人： SCOTT ANDREW
IPC分类号： A43C1/00
摘要： 8837. Scott, A. April 10. No Patent granted (Sealing fee not paid). Lacing-fastenings; laces.-The stiffened edges of a boot or shoe upper are provided with an imitation lacing A, Fig. 2, and are drawn together by passing the ends of this lacing round lacing hooks b. In the form shown in Figs. 5, 7 this lacing A is secured at the eyelet c from which it passes through eyelets c' and through an eyelet c . Short pieces of lace a , a are secured to the main lace A at points a and a piece a attached on one side at point a' is secured on the other side at a point a to the lace A. The stiffening-member may be provided with eyelets if deisred.

5. 发明申请

WO0217970A3 METAL RADIONUCLIDE LABELLED CD-30 ANTIBODIES AND USES THEREOF 审中-公开
标题翻译：金属放射性核素标记的CD-30抗体及其用途
公开(公告)号：WO0217970A3
公开(公告)日：2003-01-09
申请号：PCT/US0126335
申请日：2001-08-23
申请人： LUDWIG INST CANCER RES , LEE FOOK THEAN , SCOTT ANDREW , RENNER CHRISTOPH , PEREUNDSCHUH MICHAEL
发明人： LEE FOOK THEAN , SCOTT ANDREW , RENNER CHRISTOPH , PEREUNDSCHUH MICHAEL
IPC分类号： A61K51/10
CPC分类号： A61K51/1093 , A61K51/1021
摘要： The invention relates to metallic radionuclide containing immunoconjugates. The immunoconjugates bind specifically to the CD30 molecule. Both diagnostic and therapeutic uses of the immunoconjugates are described. The preferred immunoconjugates are monoclonal antibodies to which In or Y is bound via a chelator.
摘要翻译：本发明涉及含有免疫缀合物的金属放射性核素。免疫缀合物特异性结合CD30分子。描述了免疫缀合物的诊断和治疗用途。优选的免疫偶联物是通过螯合剂结合<111> In或90 Y的单克隆抗体。

6. 发明授权

US841886A Manufacture of nitroglycerin. 失效
标题翻译：硝酸盐的制备。
公开(公告)号：US841886A
公开(公告)日：1907-01-22
申请号：US1906320336
申请日：1906-06-05
申请人： NATHAN FREDERIC LEWIS , THOMSON JAMES MILN , RINTOUL WILLIAM , SCOTT ANDREW
发明人： NATHAN FREDERIC LEWIS , THOMSON JAMES MILN , RINTOUL WILLIAM , SCOTT ANDREW
CPC分类号： C07C201/02

7. 发明申请

WO2008115404A1 TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS 审中-公开
标题翻译：使用EGFR抗体和SRC抑制剂及相关制剂的治疗方法
公开(公告)号：WO2008115404A1
公开(公告)日：2008-09-25
申请号：PCT/US2008003369
申请日：2008-03-14
申请人： LUDWING INST FOR CANCER RES , CAVENEE WEBSTER , FURNARI FRANK , JOHNS TERRANCE GRANT , SCOTT ANDREW
发明人： CAVENEE WEBSTER , FURNARI FRANK , JOHNS TERRANCE GRANT , SCOTT ANDREW
IPC分类号： C12P21/08
CPC分类号： A61K31/506 , A61K31/517 , A61K39/39541 , A61K45/06 , C07K2317/30 , A61K2300/00
摘要： The present invention relates to the treatment of EGFR-mediated disease, particularly cancer by inhibiting or blocking EGFR and src in combination or simultaneously. The invention relates to treatment, prevention, or modulation of cancer, particularly EGFR- mediated disease, with one or more EGFR modulator and src inhibitor in combination. The invention further relates to the treatment of cancer with anti-EGFR antibodies and src inhibitors. Methods and compositions for treatment of cancer with the antibody anti- EGFR mAb806 in combination or series with a src inhibitor or src inhibitors are described.
摘要翻译：本发明涉及通过组合或同时抑制或阻断EGFR和src来治疗EGFR介导的疾病，特别是癌症。本发明涉及一种或多种EGFR调节剂和src抑制剂组合治疗，预防或调节癌症，特别是EGFR-介导的疾病。本发明还涉及用抗EGFR抗体和src抑制剂治疗癌症。描述了与抗src抑制剂或src抑制剂组合或串联的用于治疗抗EGFR抗体mAb806的癌症的方法和组合物。

8. 发明申请

WO2013176724A3 LIGHTWEIGHT WEAPONS PLATFORM 审中-公开
标题翻译：轻武器平台
公开(公告)号：WO2013176724A3
公开(公告)日：2014-01-30
申请号：PCT/US2013028666
申请日：2013-03-01
申请人： CANTINE CHRISTOPHER , CROGHAN JOHN , SCOTT ANDREW
发明人： CANTINE CHRISTOPHER , CROGHAN JOHN , SCOTT ANDREW
IPC分类号： B64D7/02
CPC分类号： B64D7/00 , B64D9/00 , F41A23/00
摘要： A mounting system is provided including a center platform having a plurality of mounting lugs for mounting the center platform transversely extending at least partially through an aircraft cabin with a first end and second end of the center platform adjacent a respective first and second side opening of the aircraft cabin. A first support pylon may be removably coupleable to the first end of the center platform to extend outwardly from a first side of the aircraft. A second support pylon may be removably coupleable to the second end of the center platform to extend outwardly form a second side of the aircraft. A modular floor component may be removably coupleable relative to a longitudinal side of the center platform to provide a substantially planar load surface including a top portion of the modular floor component and a top surface of the center platform.
摘要翻译：提供一种安装系统，其包括具有多个安装凸耳的中心平台，所述安装凸耳用于安装中心平台至少部分地穿过飞机机舱横向延伸，其中心平台的第一端和第二端邻近相应的第一和第二侧开口飞机舱。第一支撑塔可以可拆卸地联接到中心平台的第一端，以从飞行器的第一侧向外延伸。第二支撑塔可以可拆卸地联接到中心平台的第二端，以向外延伸形成飞行器的第二侧。模块化地板部件可以相对于中心平台的纵向侧面可拆卸地联接，以提供包括模块化地板部件的顶部和中心平台的顶面的基本平坦的载荷表面。

9. 发明申请

WO2009022161A3 SYSTEMS AND METHODS FOR PRESENTING USER GENERATED DATA IN A USER INTERFACE ACCORDING TO USER RELEVANCE 审中-公开
标题翻译：用户界面中用户生成数据的系统和方法
公开(公告)号：WO2009022161A3
公开(公告)日：2009-07-23
申请号：PCT/GB2008002795
申请日：2008-08-15
申请人： RUMMBLE LTD , COX CLIVE , SCOTT ANDREW
发明人： COX CLIVE , SCOTT ANDREW
IPC分类号： G06F17/30
CPC分类号： G06F17/30867 , G06Q10/10
摘要： A system and method for analysing user generated content data which includes a first item of data associated with a first user from a plurality of users is described. The system comprises memory configured to store user data representative of links between the plurality of users, an assigned relevance value for the first item assigned to the first item by the first user and an assigned trust value assigned to the first user as an indicator of how relevant an assigned relevance value generated by the first user is. The system also comprises a processing device connected to the memory which is configured to: by using the user data, generate for an identified user, a separation value of the first user, and, by using the assigned relevance value and the separation value, generate a derived relevance value of the first item for the identified user. The separation value represents the number of links which connect the first user and the identified user.
摘要翻译：描述用于分析用户生成的内容数据的系统和方法，其包括与多个用户相关联的第一用户的第一数据项。该系统包括被配置为存储表示多个用户之间的链接的用户数据的存储器，由第一用户分配给第一项目的第一项目的分配的相关性值和分配给第一用户的分配的信任值作为如何相关的由第一用户生成的分配的相关性值是。该系统还包括连接到存储器的处理设备，其被配置为：通过使用用户数据，为所识别的用户生成第一用户的分离值，并且通过使用所分配的相关性值和分离值，生成所识别的用户的第一项目的派生相关值。分离值表示连接第一用户和已识别用户的链接数。

10. 发明申请

WO02083171A3 CANCER TREATMENT BY USING FAP-ALPHA SPECIFIC ANTIBODIES 审中-公开
标题翻译：使用FAP-ALPHA特异性抗体治疗癌症
公开(公告)号：WO02083171A3
公开(公告)日：2003-03-06
申请号：PCT/EP0204041
申请日：2002-04-11
申请人： BOEHRINGER INGELHEIM INT , BOEHRINGER INGELHEIM PHARMA , AMELSBERG ANDREE , SCOTT ANDREW , TANSWELL PAUL
发明人： AMELSBERG ANDREE , SCOTT ANDREW , TANSWELL PAUL
IPC分类号： A61K51/10 , A61P35/00 , C07K16/40 , A61K39/395
CPC分类号： A61K51/1096 , A61K51/1075 , A61K2039/505 , C07K16/40 , C07K2317/24 , C07K2317/56
摘要： The invention involves the therapeutic use of humanized antibodies, which bind specifically to the molecule known as FAP alpha . The invention relates to methods of treatment, in particular cancer treatment, pharmaceutical compositions comprising said antibodies, and use of said antibodies in the preparation of a medicament for cancer treatment. Said antibody preferably is the antibody known as BIBH 1, which has a very short half life and when labelled with a therapeutic label, is effective in treating cancers such as colorectal cancer and non small cell lung cancer. ing the antibody are disclosed.
摘要翻译：本发明涉及治疗性使用人源化抗体，其特异性结合称为FAPα的分子。本发明涉及治疗方法，特别是癌症治疗，包含所述抗体的药物组合物和所述抗体在制备用于癌症治疗的药物中的用途。所述抗体优选是称为BIBH1的抗体，其具有非常短的半衰期，并且当用治疗标记物标记时，可有效治疗癌症如结肠直肠癌和非小细胞肺癌。公开了抗体。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式